Buyback Spend for Solventum (SOLV)
Buyback Spend for Solventum (SOLV): headline value $0. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
SOLV
Currently viewingBuyback SpendSwitch metric
Latest period
$0
YoY change
N/A
5Y CAGR
N/A
Peak year (2020)
$0
Latest annual
$0
Buyback Spend history chart for Solventum (SOLV) from 2020 to 2025
Buyback Spend history table for Solventum (SOLV) from 2020 to 2025
| Fiscal year | Period ended | Reported | Buyback Spend | YoY |
|---|---|---|---|---|
| 2025 | $0 | — | ||
| 2024 | $0 | — | ||
| 2023 | $0 | — | ||
| 2022 | $0 | — | ||
| 2021 | $0 | — | ||
| 2020 | $0 | — |
Buyback Spend values are taken from Solventum's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Solventum (SOLV) buyback spend is $0.
Within Healthcare, Solventum (SOLV) ranks 8th among 8 peers we track. The peer median for buyback spend is $2.75B.
Solventum Buyback Spend by Year
Solventum Buyback Spend 2025: $0
Solventum buyback spend in 2025 was $0.
Solventum Buyback Spend 2024: $0
Solventum buyback spend in 2024 was $0.
Solventum Buyback Spend 2023: $0
Solventum buyback spend in 2023 was $0.
Solventum Buyback Spend 2022: $0
Solventum buyback spend in 2022 was $0.
Solventum Buyback Spend 2021: $0
Solventum buyback spend in 2021 was $0.
See more financial history for Solventum (SOLV).
Sector peers — Buyback Spend
Companies in the same sector as Solventum, ranked by their latest buyback spend.
| Company | Buyback Spend | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $5.95B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $5.54B | Healthcare |
| Merck & Co., Inc. (MRK) | $5.08B | Healthcare |
| Eli Lilly and Company (LLY) | $4.11B | Healthcare |
| Novo Nordisk A/S (NVO) | $1.39B | Healthcare |
| AbbVie Inc. (ABBV) | $980.00M | Healthcare |
| AstraZeneca PLC (AZN) | $719.66M | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
Frequently asked questions
What is Solventum's buyback spend?
Latest reported buyback spend for Solventum (SOLV) is $0 (period ending December 31, 2025).
When did Solventum buyback spend hit its highest annual value?
Solventum buyback spend reached its highest annual value of $0 in 2020.
What was Solventum buyback spend in 2024?
Solventum (SOLV) buyback spend in 2024 was $0.
What was Solventum buyback spend in 2025?
Solventum (SOLV) buyback spend in 2025 was $0.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
SOLV Overview
Company profile, financial tools, and key metrics
SOLV Revenue Counter
Earns $263.98 every second. See per minute, hour, and day.
SOLV Earnings Counter
Earns $49.34 per second net profit. See per minute, hour, and day.
SOLV Economic Scale
Exceeds Montenegro's GDP. Compare with world economies.
SOLV What If Invested
What if you had invested $1,000? See historical returns from any date.
SOLV How It Makes Money
Discover visual breakdown of $8.32B in revenue — where it comes from and where it goes.
SOLV Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
SOLV Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
SOLV Daily Price Character
Steady · 48.6% historical win rate (green days). Streaks & record days.
SOLV Buybacks
See repurchase history & metrics. Shareholder yield & SBC comparison.